semaglutide patents New Delhi, March 19, 2026 – On Friday, the key patent on semaglutide—the active molecule in Novo Nordisk's blockbuster drugs Ozempic and Wegovy—expired in India, marking a pivotal shift in the country's The Semaglutide Patent Puzzle: Evergreening
Pay in 4 interest-free payments of $5.56 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13























